PT Dosni Roha Indonesia (ZBRA) Stock Analysis 2026: Business Model, Financial Performance, Risks, and Investment Outlook
 |
| PT Dosni Roha Indonesia (ZBRA) |
Worldreview1989 - PT Dosni Roha Indonesia Tbk (IDX: ZBRA) is a small Indonesian public company that has undergone a significant transformation from its historical transportation business into a distribution and logistics-focused company.
For U.S. investors, ZBRA is an interesting example of an emerging-market small-cap stock: the company operates in industries connected to healthcare distribution, logistics, and supply-chain services, but its financial profile also presents significant risks, including losses, financing costs, liquidity concerns, and limited stock-market liquidity.
This article examines what PT Dosni Roha Indonesia does, how its business has changed, its financial performance, balance-sheet condition, key risks, and what investors should consider before treating ZBRA as an investment opportunity.
Important: ZBRA is listed on the Indonesia Stock Exchange (IDX), not a U.S. exchange. American investors should therefore consider foreign-market access, currency risk, liquidity, corporate-governance risk, and differences between Indonesian and U.S. securities-market regulations.
What Is PT Dosni Roha Indonesia?
PT Dosni Roha Indonesia Tbk, ticker ZBRA, is an Indonesian publicly listed company whose current business is centered primarily on distribution and logistics activities.
The company was historically known as PT Zebra Nusantara Tbk, reflecting its former transportation-related business. Its corporate transformation subsequently shifted the company toward distribution, logistics, and supply-chain activities.
ZBRA's shares were originally listed on the Indonesian stock market in 1991. The company's name was changed from PT Zebra Nusantara Tbk to PT Dosni Roha Indonesia Tbk in 2022 as part of its broader business transformation.
The company describes its strategic direction around distribution, logistics, and e-logistics. A 2025 public-expose announcement specifically identified distribution, logistics, and e-logistics as key business areas.
For investors, this transformation is important because ZBRA should not be analyzed simply as a legacy transportation company. Its current investment thesis depends much more heavily on whether the distribution and logistics businesses can generate sustainable margins and positive cash flow.
ZBRA's Business Model
The easiest way for a U.S. investor to understand ZBRA is to think of it as a small emerging-market distribution and supply-chain company.
Its business model is potentially attractive because distribution companies can benefit from:
Increasing healthcare consumption
Growth in pharmaceutical distribution
Expansion of modern retail
Increasing demand for logistics services
E-commerce and digital supply chains
Greater outsourcing of distribution activities
Indonesia's large and geographically dispersed consumer market
Indonesia is particularly relevant to logistics investors because its geography creates significant distribution challenges. The country consists of thousands of islands, making transportation infrastructure, warehousing, inventory management, and regional distribution important components of the economy.
The Indonesian government has also historically emphasized reducing logistics costs and improving national distribution infrastructure. Bank Indonesia has highlighted policies involving regional distribution centers, transportation-cost reduction, standardized domestic-goods documentation, and improvements to national logistics systems.
That creates a potentially favorable long-term industry environment.
However, industry growth does not automatically translate into shareholder returns.
The company's financial statements show why investors need to look beyond revenue growth.
ZBRA Financial Performance
One of the most important lessons from ZBRA's financial history is that revenue alone does not tell the full investment story.
The company's consolidated financial statements show the following financial profile for the period reported around fiscal 2023:
| Financial Metric | FY2023 |
|---|---|
| Revenue | IDR 1.724 trillion |
| Cost of Revenue | IDR 1.368 trillion |
| Gross Profit | IDR 356.1 billion |
| Selling Expenses | IDR 64.9 billion |
| G&A Expenses | IDR 288.9 billion |
| Finance Costs | IDR 163.1 billion |
| Net Loss | IDR 144.8 billion |
| Total Assets | IDR 3.283 trillion |
| Total Liabilities | IDR 2.169 trillion |
| Total Equity | IDR 1.114 trillion |
The figures are derived from the company's consolidated financial reporting.
The first major issue: revenue declined
ZBRA generated approximately IDR 1.724 trillion in revenue, compared with approximately IDR 2.958 trillion in the previous year.
That represents a decline of roughly:
-41.7%
This is significant.
A company operating in a growth-oriented distribution and logistics market ideally needs to demonstrate either:
consistent revenue growth,
improving margins, or
strong free cash flow generation.
ZBRA's historical numbers do not yet provide a strong combination of those three characteristics.
Gross Margin Analysis
ZBRA generated approximately IDR 356.1 billion in gross profit from IDR 1.724 trillion of revenue.
That produces a gross margin of approximately:
20.7%
Calculation:
IDR 356.1B ÷ IDR 1,724.5B = 20.65%
A roughly 20.7% gross margin is not necessarily problematic for a distribution business.
The bigger issue is what happens below the gross-profit line.
ZBRA reported approximately:
IDR 64.9 billion in selling expenses
IDR 288.9 billion in general and administrative expenses
Combined selling and administrative expenses were therefore approximately:
IDR 353.8 billion
That amount was almost equal to the company's gross profit.
This means that even after generating more than IDR 1.7 trillion in sales, ZBRA had very limited operating profitability before financing costs and other items.
This is one of the most important issues investors should monitor.
Operating Margin
Based on the reported figures, operating profitability was extremely thin.
Gross profit:
IDR 356.1 billion
Less selling expenses:
IDR 64.9 billion
Less general and administrative expenses:
IDR 288.9 billion
This leaves only a very small operating contribution before other items.
The company's financial statements reported operating profit of only around IDR 2.3 billion for the relevant period.
That translates into an operating margin of approximately:
0.13%
In other words, ZBRA was effectively operating near break-even at the operating level.
For a potential investor, this is a warning sign.
The Biggest Financial Problem: Interest Expense
The company's financing costs are particularly important.
ZBRA reported approximately:
IDR 163.1 billion in interest and finance costs
against gross profit of approximately:
IDR 356.1 billion.
That means finance costs consumed approximately:
45.8% of gross profit
This is extremely important for investors.
Even if ZBRA improves revenue, the company must generate enough operating cash flow to service its financing obligations.
A distribution business typically operates on relatively tight margins. If borrowing costs consume a substantial portion of gross profit, shareholders may receive little benefit from revenue growth.
Net Loss
ZBRA recorded a consolidated net loss of approximately:
IDR 144.8 billion
for the reported fiscal period.
The loss attributable to the parent company's shareholders was approximately IDR 138.6 billion.
This means ZBRA was not yet generating sustainable net profitability.
For a U.S. investor accustomed to analyzing companies such as Amazon, UPS, Cencora, Cardinal Health, or McKesson, the appropriate question is not simply:
"Is the company operating in a growing industry?"
The more important question is:
"Can the company convert that industry opportunity into sustainable earnings and free cash flow?"
ZBRA has not yet demonstrated that convincingly.
Balance Sheet Analysis
The balance sheet provides another important perspective.
The reported figures showed approximately:
Total assets: IDR 3.283 trillion
Total liabilities: IDR 2.169 trillion
Total equity: IDR 1.114 trillion
The implied liabilities-to-assets ratio is approximately:
66.1%
Calculation:
IDR 2.169T ÷ IDR 3.283T = 66.1%
That means roughly two-thirds of the company's asset base was financed through liabilities.
This does not automatically mean the company is insolvent. Distribution businesses often require significant working capital.
However, combined with persistent losses and substantial finance costs, leverage becomes a material investment risk.
Working Capital Is Critical
Distribution businesses can appear healthy on the income statement while experiencing cash-flow pressure.
Why?
Because companies often need to:
purchase inventory before selling it,
extend credit to customers,
maintain warehouses,
finance receivables,
pay suppliers,
manage inventory turnover.
ZBRA's March 2024 balance sheet illustrates this working-capital intensity.
At that point, the company reported approximately:
IDR 693.9 billion in third-party trade receivables
IDR 946.9 billion in other receivables
IDR 573.2 billion in inventory
IDR 2.899 trillion in current assets
while current liabilities were approximately:
IDR 2.171 trillion.
This creates a relatively small margin of safety for a company experiencing losses.
Current Ratio
Using the March 2024 figures:
Current Assets = IDR 2.899 trillion
Current Liabilities = IDR 2.171 trillion
Current ratio:
2.899 ÷ 2.171 ≈ 1.34x
A current ratio above 1.0x means current assets exceeded current liabilities.
That is positive.
But investors should not interpret a 1.34x current ratio as proof of strong liquidity.
A significant portion of current assets consisted of receivables, inventory, prepaid taxes and other current assets rather than cash.
Cash and bank balances were only around:
IDR 22.7 billion
at March 31, 2024.
That is a very different picture from having hundreds of billions of rupiah in immediately available cash.
Debt and Financial Leverage
ZBRA's historical financial statements show substantial dependence on financing.
At March 31, 2024, the company reported:
Current liabilities: approximately IDR 2.17 trillion
Bank loans included in current liabilities: approximately IDR 833.6 billion
Long-term bank debt: approximately IDR 77.2 billion
Consumer-financing liabilities: approximately IDR 174 billion long-term
This makes the company's debt structure an important part of the investment thesis.
A turnaround in revenue without a corresponding improvement in operating cash flow may not be enough.
ZBRA's Key Investment Opportunity
Despite the financial risks, there is a potential investment case.
1. Healthcare distribution exposure
Healthcare distribution can be relatively defensive compared with highly discretionary industries.
Demand for pharmaceutical and healthcare products tends to persist even when consumers reduce spending elsewhere.
If ZBRA can strengthen its position in healthcare distribution, it could potentially benefit from long-term healthcare demand growth in Indonesia.
2. Indonesia's large consumer market
Indonesia is one of Southeast Asia's largest economies and has a large domestic consumer base.
For a distribution company, this provides a potentially attractive long-term addressable market.
The opportunity becomes more compelling if ZBRA can improve:
regional distribution,
inventory management,
logistics efficiency,
technology integration,
customer relationships,
warehouse utilization.
3. Logistics and e-logistics
ZBRA's strategy has included logistics and e-logistics.
Digitization could potentially improve:
inventory visibility,
order processing,
route optimization,
warehouse management,
customer fulfillment,
distribution efficiency.
However, investors should distinguish between a strategic plan and a financially proven business model.
The company still needs to demonstrate that investments in these areas generate attractive returns on capital.
Major Risk: Revenue Volatility
One of the clearest risks is historical revenue volatility.
ZBRA's revenue increased dramatically during its business transformation period, but subsequently declined materially.
Historical data show revenue of approximately:
IDR 3.497 trillion in 2021
IDR 2.958 trillion in 2022
IDR 1.724 trillion in 2023
That is not the pattern of a mature, consistently compounding business.
Investors should therefore avoid extrapolating the company's earlier revenue expansion indefinitely.
Major Risk: Persistent Losses
Another concern is profitability.
The company reported substantial losses despite generating more than IDR 1.7 trillion of revenue.
This means the problem is not simply lack of scale.
ZBRA needs to address its cost structure.
The key questions for future financial reports are:
Can gross margins improve?
Can SG&A expenses decline as a percentage of revenue?
Can finance costs fall?
Can EBITDA convert into positive operating cash flow?
Can working-capital requirements be reduced?
Can the company return to sustainable net profitability?
Until those questions are answered, ZBRA should be considered a high-risk turnaround situation rather than a conventional growth stock.
 |
| PT Dosni Roha Indonesia (ZBRA) |
Major Risk: Stock Liquidity
For U.S. investors, liquidity is especially important.
ZBRA is a relatively small Indonesian listed company, and its shares can experience periods of low trading activity.
This can create:
wider bid-ask spreads,
difficulty entering large positions,
difficulty exiting during market stress,
higher price volatility,
greater price impact from relatively small orders.
The Indonesia Stock Exchange placed ZBRA under special monitoring in 2025 under criteria related to trading and financial conditions, although the company subsequently exited that special-monitoring status effective September 17, 2025. The IDX announcement cited the applicable special-monitoring criteria and confirmed ZBRA's removal.
That history is worth understanding before considering the stock.
Major Risk: Corporate Governance and Emerging-Market Risk
American investors should also account for differences between investing in Indonesia and investing in U.S.-listed companies.
ZBRA is subject to Indonesian capital-market regulations and reporting requirements.
The company is listed on the Indonesia Stock Exchange, while its securities are also registered with Indonesia's central securities depository, KSEI. KSEI identifies ZBRA as an active IDX-listed security with the stock code ZBRA and a listing date of August 1, 1991.
The company is also included in certain OJK securities classifications, including historical inclusion in OJK's list of Sharia securities.
Investors should nevertheless perform their own due diligence regarding:
related-party transactions,
shareholder concentration,
board composition,
auditor reports,
debt arrangements,
subsidiaries,
corporate actions,
disclosures to IDX and OJK.
Shareholder Concentration
Ownership concentration can influence the risk profile of a small-cap company.
As of December 31, 2024, PT Trinity Healthcare held approximately:
62.01%
of ZBRA.
The public/non-scripless shareholder category represented approximately:
21.84%
while an MKES client-repo position represented approximately:
16.15%.
For investors, concentrated ownership can have both advantages and disadvantages.
Potential advantage
A controlling shareholder may have a strong incentive to execute a long-term turnaround.
Potential disadvantage
Minority investors have less influence over corporate decisions.
Therefore, U.S. investors should pay particular attention to related-party transactions and capital-allocation decisions.
Is ZBRA Cheap?
This is where investors need to be careful.
A stock trading at a low nominal price is not automatically cheap.
For example:
A $0.01 stock can be expensive if the company continually destroys capital.
Likewise, a stock trading at a higher nominal price can be cheap if its earnings and free cash flow justify the valuation.
For ZBRA, traditional valuation metrics such as P/E may be inappropriate during periods of negative earnings.
Instead, investors should focus on:
Price-to-book value
Enterprise value-to-sales
Enterprise value-to-EBITDA
Net debt-to-EBITDA
Free cash flow
Return on invested capital
Working-capital turnover
Interest coverage
The company must first demonstrate sustainable profitability before a conventional earnings-based valuation becomes particularly meaningful.
A Simple ZBRA Investment Framework
For U.S. investors, I would divide the ZBRA thesis into three scenarios.
Bull Case
ZBRA successfully transforms its distribution and logistics operations.
Revenue stabilizes and begins growing again.
At the same time:
gross margins improve,
SG&A declines as a percentage of sales,
interest expense falls,
working capital improves,
operating cash flow becomes positive.
Under this scenario, ZBRA could potentially transition from a distressed turnaround stock into a small-cap growth story.
Base Case
Revenue remains relatively stable but margins remain weak.
The company continues operating but generates inconsistent profitability.
Under this scenario, the stock may remain highly speculative and dependent on corporate restructuring or improved market sentiment.
Bear Case
Revenue continues declining while financing costs remain high.
Working-capital requirements increase and cash generation remains weak.
Under this scenario, the company could require additional financing, asset sales, restructuring, or other forms of capital support.
For shareholders, this could result in dilution or destruction of shareholder value.
What Should Investors Watch in the Next Financial Reports?
Before buying ZBRA, investors should monitor at least these 10 indicators:
1. Revenue growth
Look for sustainable year-over-year growth.
2. Gross margin
A rising gross margin would indicate better economics.
3. SG&A/revenue
This is particularly important because administrative costs have historically consumed much of the gross profit.
4. EBITDA
EBITDA should become consistently positive.
5. Operating cash flow
This is more important than accounting earnings for assessing financial sustainability.
6. Interest expense
A reduction would significantly improve the company's earnings potential.
7. Net debt
Investors should monitor whether leverage is falling or rising.
8. Accounts receivable
Rapid growth in receivables could indicate working-capital pressure.
9. Inventory
Inventory should grow in line with sales rather than materially faster.
10. Equity
Continued losses can erode shareholders' equity over time.
Financial Scorecard
Based on the available financial information, a reasonable qualitative scorecard would look like this:
| Category | Assessment |
|---|---|
| Industry opportunity | Positive |
| Indonesia market opportunity | Positive |
| Healthcare distribution exposure | Positive |
| Revenue consistency | Weak |
| Gross margin | Moderate |
| Operating profitability | Weak |
| Net profitability | Weak |
| Debt profile | High risk |
| Interest burden | High risk |
| Liquidity | Caution |
| Stock liquidity | High risk |
| Turnaround potential | Speculative |
| Long-term investment visibility | Low |
ZBRA vs. a Typical U.S. Healthcare Distributor
It is useful for American readers to understand that ZBRA is not equivalent to a company such as McKesson, Cencora, or Cardinal Health.
Large U.S. healthcare distributors benefit from enormous scale, established supplier relationships, sophisticated logistics infrastructure, and access to deep capital markets.
ZBRA is dramatically smaller.
Therefore, investors should view it as an emerging-market small-cap distribution company with turnaround characteristics, rather than as an established global healthcare-distribution leader.
This distinction is crucial when assessing risk.
Should U.S. Investors Buy ZBRA?
For most conservative investors, ZBRA would not currently fit the profile of a traditional core portfolio holding.
The company has several attractive characteristics:
exposure to Indonesian distribution,
healthcare-related activities,
logistics opportunities,
potential digital transformation,
a large domestic market,
potential turnaround upside.
But these positives are offset by significant risks:
declining historical revenue,
persistent net losses,
high financing costs,
leverage,
working-capital requirements,
limited trading liquidity,
emerging-market risk,
concentrated ownership.
Therefore, ZBRA is better characterized as a speculative turnaround investment than a defensive or income-producing stock.
Final Investment Verdict
PT Dosni Roha Indonesia (IDX: ZBRA) is an interesting company, but the investment case depends heavily on execution.
The company's distribution and logistics businesses operate in markets with long-term structural opportunities. Indonesia's large population, expanding healthcare needs, and continuing development of its logistics infrastructure provide a potentially attractive backdrop.
However, ZBRA's historical financial statements show that revenue growth alone has not translated into shareholder profitability.
The most important issue is the company's cost and financing structure.
With approximately IDR 1.724 trillion of revenue and IDR 356.1 billion of gross profit, the company still reported a substantial net loss. Finance costs of approximately IDR 163.1 billion represented a significant burden relative to gross profit.
For that reason, investors should not ask only whether ZBRA's market is growing.
The more important question is:
Can ZBRA turn its distribution and logistics platform into a consistently profitable, cash-generating business?
If management succeeds, the company's small size could create significant upside potential.
If it fails, however, revenue growth may not be enough to protect shareholders from leverage, dilution, or continued losses.
Investment conclusion:
Risk Level: High
Investment Style: Speculative Turnaround
Suitable for: High-risk investors with emerging-market exposure
Not ideal for: Conservative income investors or investors seeking predictable earnings
Key catalyst: Sustainable return to positive operating cash flow and net profitability.
Key risk: Continued losses combined with high financing costs and working-capital pressure.
Sources and References
Investors should verify the latest disclosures directly through official Indonesian market institutions and the company's own filings.
PT Dosni Roha Indonesia Tbk – Consolidated Financial Statements
The company's financial statements provide the primary source for revenue, expenses, assets, liabilities, equity, debt, and cash-flow information.Indonesia Stock Exchange (IDX)
IDX provides official company disclosures, financial reports, corporate announcements, and special-monitoring information.Kustodian Sentral Efek Indonesia (KSEI)
KSEI identifies ZBRA as PT Dosni Roha Indonesia Tbk, listed on IDX since August 1, 1991.Otoritas Jasa Keuangan (OJK)
OJK is Indonesia's financial-services regulator and provides regulatory and securities-market information. ZBRA has appeared in OJK securities classifications.Bank Indonesia
Bank Indonesia has documented Indonesian logistics-development initiatives, including policies aimed at reducing logistics costs and improving distribution infrastructure.
Investor Disclaimer
This article is for informational and educational purposes only and should not be interpreted as personalized investment advice.
ZBRA is an Indonesian small-cap stock and may involve substantially greater liquidity, currency, regulatory, corporate-governance, and volatility risks than many U.S.-listed securities.
Investors should review the latest audited financial statements, IDX disclosures, OJK filings, corporate actions, and risk factors before making an investment decision.
Past financial performance does not guarantee future results.
About the Author
David Mulyana is the founder and editor of WorldReview1989, an independent publication dedicated to finance, investing, insurance, business, technology, and digital marketing.
He researches and writes in-depth articles that help readers understand complex financial topics through clear explanations, practical insights, and data-driven analysis. His editorial focus includes stock market investing, cryptocurrencies, banking, personal finance, business insurance, real estate, startup strategies, and emerging technology trends.
Every article published on WorldReview1989 is created with a commitment to accuracy, transparency, and reader value. Content is reviewed regularly to reflect the latest market developments, industry updates, and publicly available information from trusted sources.
Editorial Principles
- Accuracy before speed
- Independent and unbiased analysis
- Clear, easy-to-understand explanations
- Information supported by reputable public sources
- Regular updates to maintain content relevance
Areas of Expertise
- Personal Finance
- Investing & Stock Market
- Cryptocurrency & Blockchain
- Insurance
- Banking
- Real Estate
- Business & Entrepreneurship
- Digital Marketing
- Financial Technology (FinTech)
About WorldReview1989
WorldReview1989 provides educational content for readers seeking reliable information about finance, investment opportunities, insurance, business strategies, and technology. The website aims to simplify complex financial concepts and empower readers to make informed decisions.
Disclaimer: The information published on WorldReview1989 is for educational and informational purposes only. It should not be considered financial, legal, tax, or investment advice. Readers should consult qualified professionals before making financial decisions.
David Mulyana writes about stocks, financial markets, investment strategies, insurance and emerging-market opportunities, with a focus on helping readers understand financial data and investment risks.
Investment Disclaimer
This article is for educational and informational purposes only and should not be considered personalized investment, tax or financial advice. Australian stocks can be volatile and involve currency, market, commodity, regulatory and geopolitical risks. Past performance does not guarantee future results. U.S. investors should conduct their own due diligence and consult a qualified financial or tax professional before investing.
Comments
Post a Comment